Ophthalmology Drugs Market Global Briefing 2018

Starting Price : $ 1000.00 | Pages : 34 | Published : January 2018 | SKU CODE : 2773 | Format :

The ophthalmology drugs market covers drugs that are used in the treatment of eye related diseases such as refractive errors, cataracts, glaucoma, conjunctivitis, retinal diseases, and macular degeneration. Some of the major ophthalmic drugs include Eylea, Lucentis, Restasis, Vigamox, Azopt, and Lotemax.  

The top five companies covered are Novartis AG, F. Hoffmann-La Roche Ltd., Allergan Plc., Valeant Pharmaceuticals Intl Inc., and Bayer AG. Novartis AG Group was the largest company in the ophthalmology drugs market.

The countries covered are USA, China, Germany, Brazil, Japan, UK, Spain, Russia, France, Australia, Italy, India and rest of the world.

The global ophthalmology drugs market was valued around $28 billion in 2017. North America was the largest region in the ophthalmology drugs market in 2017, accounting for around 31% of the total market. The USA was the largest country in the market accounting for around 28% of the total market.

Development of combination therapies for the treatment of eye related diseases including glaucoma is an emerging trend in the ophthalmology drugs market. Combination therapy involves use of more than one medication or drug to treat a disease. These combinational therapies reduce the frequency of eye drops or drug administration, and reduce the possibility of vascular endothelial growth factor (VEGF) expression, choroidal neovascularization and inflammation.

The ophthalmology drugs market is segmented into other Ophthalmology Drugs, Dry Eye Medication, And Antiglaucoma Drugs. Other Ophthalmological Drugs include drugs for retinal disorders, anti-infectives and allergies. Dry Eye Medications Drugs include drugs to reduce eyelid inflammation, cornea inflammation and tear-stimulating drugs. Anti-glaucoma Drugs are used for the treatment of glaucoma, a disease that damages eye’s optic nerves.

Next-gen Biologics- The Way Forward

The Telemedicine Technology Market Will More Than Double by 2022

Minor Orthopedic Replacement Implants Global Market Exceeds $1.5 Billion

Minor orthopedic implant market to be worth $2.2 billion by 2021, analysts say

Organs-on-Chips to Revolutionize the Drug Development Industry

Russia’s Musculoskeletal Drugs Market Is Catching Up With The Rest Of Europe

The Fastest Growing Regions for Dermatological Drug Sales Are the Middle East and South America

Growth of Middle Class Is Causing Heart Drugs Market In Asia Pacific To Accelerate, Says TBRC

Blood Glucose Test Strips Global Market Report 2018

View Report

Veterinary Services Global Market Report 2018

View Report

Podiatry Services Global Market Strategies and Opportunities to 2021

View Report

Minor Orthopedic Implants Replacement Global Market Opportunities And Strategies To 2021

View Report

Biologics Global Market Opportunities And Strategies To 2021

View Report

Pharmaceutical Drugs Global Market Opportunities And Strategies To 2021

View Report

Blood Glucose Test Strips Global Market Opportunities And Strategies To 2021

View Report

Veterinary Serices Global Market Opportunities And Strategies To 2021

View Report

Call Us

+1 3156230293

(Americas)

+44 2071930708

(Europe)

+91 8897263534

(Asia & Others)